Caryl Baron
First SEC filing: Nov. 1, 2022 · Latest: Nov. 1, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 29, 2023 | ICUCW | A | 20,293 | · | · | 139,872 Direct | +16.97% | Acquired | (price as of 2026-10-05) |
| Sept. 22, 2023 | ICUCW | J | 15,070 | · | · | 119,579 Direct | +14.42% | Acquired | (price as of 2026-10-05) |
| Sept. 15, 2023 | ICUCW | A | 4,110 | · | · | 104,506 Direct | +4.09% | Acquired | (price as of 2026-10-05) |
| Aug. 31, 2023 | ICUCW | A | 3,374 | · | · | 100,396 Direct | +3.48% | Acquired | (price as of 2026-10-05) |
| Aug. 15, 2023 | ICUCW | A | 2,031 | · | · | 97,022 Direct | +2.14% | Acquired | (price as of 2026-10-05) |
| June 9, 2023 | ICUCW | F | 15,070 | $0.53 | $7,987 | 94,991 Direct | -13.69% | Disposed | -97.2% (price as of 2026-10-05) |
| June 9, 2023 | ICUCW | A | 56,869 | · | · | 110,061 Direct | +106.91% | Acquired | (price as of 2026-10-05) |
| April 6, 2023 | ICUCW | A | 16,621 | · | · | 16,621 Direct | · | Acquired | (price as of 2026-10-05) |
| April 6, 2023 | ICUCW | A | 11,080 | · | · | 53,192 Direct | +26.31% | Acquired | (price as of 2026-10-05) |
| Oct. 28, 2022 | ICUCW | A | 19,685 | · | · | 19,685 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 28, 2022 | ICUCW | A | 4,796 | · | · | 4,796 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 28, 2022 | ICUCW | A | 42,112 | · | · | 42,112 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 6, 2023 | ICUCW | Stock Option (Right to Buy) | Common Stock | $1.84 | April 6, 2033 | 16,621 | Acquired |
| Oct. 28, 2022 | ICUCW | Stock Option (Right to Buy) | Common Stock | $0.55 | Jan. 1, 2031 | 19,685 | Acquired |
| Oct. 28, 2022 | ICUCW | Stock Option (Right to Buy) | Common Stock | $10.00 | March 20, 2030 | 4,796 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $210,000 | $30,000 | $11,080 | · | · | · | · | $267,701 |
| 2022 | $160,000 | · | $351,110 | · | $15,000 | · | · | $526,110 |
| 2021 | $150,000 | $56,000 | · | · | · | · | · | $212,531 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.